Omar Khan

Deal activity remains lethargic as of September 2024 as it continues to be impacted by high capital costs and regulatory scrutiny. However, sectors like pharma services are showing growth, and projections suggest a rebound in 2025. Looking for more on the latest trends and transaction activity across the industry?

11

I’m optimistic about the potential of generative AI to reduce provider burnout and improve provider-patient interactions. However, that optimism is tempered by the data that indicates the technology is not quite ready yet. Bright Ventures is interested in digital health founders who understand the realities of provider-patient interactions, and the role technology can play in strengthening clinical outcomes. Which founders and teams are getting this right? Tag them in the comments below.

50

2 Comments

I’m happy to share a recent report from BCG on how patient analytics can play a crucial role in improving #healthequity. The report focuses on the significant disparities in treatment outcomes for Heart Failure with Reduced Ejection Fraction (HFrEF). The study reveals critical gaps, particularly in urban underserved areas, calling for urgent and strategic interventions. Read the report to learn about key actions #healthcare leaders can take to improve #healthequity: https://lnkd.in/euzj3tzW

17

My colleagues, Eric Berger, Robbie Sandig, and KC George shares how large and small pharma companies are succeeding with generative AI and the three-tiered approach guiding them to the forefront. Key takeaways include the importance of priming operating models and leveraging scale for breakthroughs.

3

1 Comment

The (Healthcare) Ground Beneath Our Feet… This year it is likely that over $10 billion will be invested in the digital health sector – a robust amount, no doubt, but inconsequential when compared to the amount of capital tied up in healthcare real estate assets, which is estimated to be $1.2 trillion by Jones Lang Lasalle. Of that amount, approximately $790 billion is in the hospital sector while the remaining $490 billion is in medical office assets. It is estimated that there are 48.6k facilities with 3.4 billion square feet of healthcare real estate, 42% of which are owned by REITs and another 33% held by other private investment vehicles. Much of the digital health investment is meant to make the physical healthcare infrastructure more productive: greater operating efficiencies, greater patient throughput, more relevant personalized care models with better outcomes. As the healthcare system is being pushed to be more distributed to lower cost sites of care, accelerated now by the rapid proliferation of automation and AI capabilities, the potential impact on healthcare infrastructure assets will be profound. Thoughts on what that might look like... https://lnkd.in/eTfAdUbS #digitalhealth Flare Capital Partners

113

6 Comments

Excited to announce Frist Cressey Ventures' investment in Qualified Health and privileged to partner w/ SignalFire, Healthier Capital, Town Hall Ventures and others!   Healthcare costs are increasing at a faster rate than ever before, with the US spending nearly twice as other wealthy countries and still ranking bottom in outcomes. It's a story you've all heard - - US healthcare is known for astronomical inefficiencies, waste, workforce supply constraints, fragmented access, appalling patient experiences, and driving patients and businesses into debt.   Yes these problems present opportunities. But opportunities are limited to the system's appetite for change, desire and incentive to try something new and the innovation available. At FCV we believe we've hit the trifecta with Generative AI. Generative AI has given us truly transformational tools in the toolkit and the healthcare ecosystem is demanding to absorb its benefits. This perfect collision of supply and demand means healthcare is poised for big change.   Generative AI is everywhere, it's buzzy, it dangles hope and opportunity. But many things need to be true for the Gen AI transformation in healthcare to take hold, such as but not limited to:   💡 Patient lives and data need to remain safe: We believe in a highly regulated and human life-touching sector such as healthcare we must ensure Gen AI can drive to unrivalled savings and improvements in the quality of care WHILE not putting patient lives or data at risk.   💡 Systems need to own their utilization of Gen AI: We believe systems will use some hybrid of external partners and homegrown solutions but importantly will want full control of data provisioning and utilization as well as the ability to solve an unlimited number of nuanced issues and not cookie cutter algorithms.   💡 Costs need to be looked at on an enterprise level: We believe the speed of innovation in Gen AI means costs will continue decreasing dramatically but at an enterprise level this will still not be a small detail. Systems will want the ability to understand costs and delegate as needed for the outcomes desired at the organizational level.   Enter Qualified.   We knew when we met Justin Norden, MD, MBA, MPhil and team we were standing in front of changemakers. These individuals have lived and breathed the true application and implementation of Generative AI far before we were asking ChatGPT to write our emails. In fact, if you’ve ever driven in a Waymo you’ve benefited from past products this team has built.   Qualified Health is on a mission to enforce governance in Gen AI, allow systems to rapidly build for their needs, monitor and make decisions for all GenAI (homegrown and external) and accelerate the value the sector can glean from these new technologies.   Huge shout out to William T., Tommaso Auerbach and Jamie Kuntz for their hard work!

240

14 Comments

As Thomas Kawalec mentioned, technology is no longer a "nice to have" - it's essential for building a strong, adaptable MedTech company. Accenture is committed to continuous improvement, and we are tackling this with tech-powered visibility & predictability, shift-left engineering, and digital workforce development for our clients. P.S. Dive deeper into these strategies in our latest blog post: https://lnkd.in/dj227sYn

64

GenAI’s potential in #healthcare extends across diagnostics, patient care, and beyond. Imagine AI-powered tools that streamline patient interactions, refine diagnosis, and optimize treatments—all while lowering costs. The tech is reshaping the value of care and patient outcomes in real time. Learn more: https://on.bcg.com/4fBW3f5

6

The pandemic caught businesses off guard, but they can prepare for the next looming disruption to semiconductor supply chains—the AI chip shortage. Success will hinge on proactive vigilance, strategic foresight, and swift action to reinforce supply chains. Learn more in our annual #tech report. https://bit.ly/3YBEqqh

2

A little late, even though this process started in July.... Excited to share our latest investment in Heads Together Health!! We met Steve DeVrieze in October last year, and we think they are poised for impressive growth! Read more here: https://lnkd.in/ecYcqqkn #earlystagestartup #earlystageinvesting #VCinvestment #ncstartups #nctechstartups

22

Anne Wojcicki, CEO of 23andMe, has announced plans to take the genetic testing company private. This strategic move aims to provide more flexibility in navigating regulatory challenges and to accelerate growth opportunities. The decision follows a trend of health tech companies seeking private ownership to focus on long-term objectives. Wojcicki highlighted the importance of this shift to maintain the company's commitment to innovation and customer-centric services. Taking 23andMe private reflects a bold step towards enhancing its position in the rapidly evolving genomics industry. Read more about this exciting development here: https://lnkd.in/gdrC3a64 #genomics #IPO #privatisation #23andMe

13

Some VC investors believe that brick and mortar - referring to a physical presence of some kind - should be avoided at all costs. Yet, the track record of clinic and hybrid care businesses in health care indicates otherwise. ==> One Medical (sold for $3.9 billion to Amazon), Oak Street (bought by CVS for $10.6 billion), Lifestance (IPO at $7.5 billion market cap), and PE-backed Premise Health (acquired by OMERS Private Equity for $1.1 billion) If a clinic is indicated as the optimal way to deliver care for that patient population, there are creative ways to build and operate them. Full article below with advice and strategies on how to build and operate hybrid clinics from my teammate Anarghya Vardhana from Maveron, Amir Dan Rubin from OneMedical Group, Steven Eidelman from Modern Animal and more!

13

1 Comment

AI has the potential to transform patient care delivery and life sciences innovation. Our team at Boston Consulting Group (BCG) and Massachusetts High Technology Council – in collaboration with leaders from industry, hospitals, and academia – examined AI’s impact on healthcare and life sciences. Our whitepaper articulates a strategy to establish Massachusetts as the global leader in “applied” AI within these sectors, using AI to improve patient outcomes, promote health equity, and advance breakthrough innovation.   Read more about the recommendations and the future of healthcare here:

5

Join us tomorrow for a panel discussion on the complex relationship many FirstGens have to money and how that affects founders, investors, operators and others. See you tomorrow! https://lu.ma/9rixyzgs

24

2 Comments

Check out my BCG colleagues recent report that focuses on improving #healthequity with patient analytics. The research unveils significant disparities in the treatment of Heart Failure with Reduced Ejection Fraction (HFrEF) across the United States. Focusing on areas with notably low engagement, particularly in under-served urban areas. Explore the findings and actionable strategies here: https://lnkd.in/ec-GHthB

7

AI and Med Tech in Focus   AI System Developed to Identify Pathology in Tissues Engineers at Washington State University have developed an AI tool that uses images of human and animal tissue to detect abnormalities faster and more accurately than people. The AI algorithm was trained using images from past studies that involved kidney, testes, ovarian, prostate, breast and lymph node abnormalities. The new model detected disease in minutes—current processes take humans several hours and require specialized teams to check each other’s work. It was also found to be more accurate, sometimes detecting instances that humans had missed. The engineers designed the system to handle the processing load of the high-resolution gigapixel images by breaking them down into smaller tiles but still retaining the overall context of the tissue sample—akin to the zoom feature on a microscope or phone camera. Aside from getting diagnostic results more accurately and quickly, the new system also shows promise in epigenetics (the study of molecular processes that change gene behavior without changing underlying DNA). Epigenetic researchers can perform analyses and get results that used to take a year or more in just a couple of weeks. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

1

“AI will usher in far greater transparency across the healthcare value chain” As we enter 2025, Mark Sullivan at Fast Company asked me to answer the question, "In what ways will AI have changed life by next year?" The healthcare industry immediately sprung to mind. At Northzone, we believe that AI's impact within the healthcare industry is only beginning to be realized. While broader LLMs and horizontal AI have led the way until now, vertical AI agents capable of actually executing workflows will be transformative to key industries like health. We’re already seeing the massive success of products that can transcribe and summarize patient-doctor conversations, but what if health system AI agents could also follow up with a pharmacist, bill an insurance provider, or automatically order new medical supplies? Those will be the companies we’ll be talking about in a decade’s time. You can read my full thoughts via this link:

20

3 Comments